• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL CERENOVUS ENTERPRISE; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL CERENOVUS ENTERPRISE; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number ENC452200
Medical Device Problem Codes Premature Activation (1484); Failure to Advance (2524)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/22/2026
Type of Reportable Event Malfunction
Event or Problem Description
A healthcare professional reported that during an endovascular embolization procedure, a 4.5mmd 22mml enterprise2 vascular reconstruction device (product code: enc452200, lot number: 10056839) was impeded in y connector and could not be pushed into the unspecified microcatheter (mc) the stent was found detached from the delivery wire in the y connector.The doctor removed the stent and microcatheter from the patient and replaced them with new devices to complete the procedure.Additional event information received on 26-mar-2026 indicated that a guidewire was used in the microcatheter prior to using the enterprise system.There was flushing during the procedure.They were able to torque the device.It is unknown if there was evidence of physical material within the device.The microcatheter did not kink/bent.There was no excessive force used with the devices.There was no procedure prolongation/delay due to the event.
 
Additional Manufacturer Narrative
Manufacturer ref # (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section h3 - the device is available to be returned for evaluation and testing.However, it has not been received to date.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Updated sections on this medwatch: b4, g3, g6, h2, h3, h6 and h11.The device was returned to j&j medtech for further evaluation.A non-sterile 4.5mmd 22mml enterprise2 vascular reconstruction device was received contained in the decontamination pouch.Upon receiving the device, visual inspection was performed, and as described in the event, the stent was detached from the delivery system.The stent was inspected under magnification, and the markers on one side were bent.The stent was fully expanded; both ends were completely flared.The proximal end of the positioning coil of the delivery wire was found stretched.The delivery wire was subjected to dimensional analysis and those specifications that control the attachment and delivery of the stent were found within specifications.A device history record (dhr) was performed, and no internal actions were identified.Although the detached stent prevented functional testing for the impeded condition reported, the customer complaint is confirmed based on the damaged delivery wire and bent stent.It is possible that in an effort to overcome the impeded condition reported, excessive force was inadvertently applied during the device advancement which ultimately led to the damage found in the delivery wire and stent, and detachment of the stent.It is possible that clinical and procedural factors, including device manipulation and operator's technique, may have contributed to the reported failure.At this time, there is no evidence to support that the issue reported in the complaint is a result of a defect inherently related to the device.As part of the j&j medtech quality process, all devices are manufactured, inspected, and released to approved specifications.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no internal action is required.It should be noted that product failure could be caused by multiple factors.The instructions for use (ifu) do contain the following recommendations: do not apply undue force if resistance is encountered at any point during stent manipulation.Withdraw the unit and advance a new one.Confirm the tip of the delivery wire is entirely within the introducer.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Updated sections on this medwatch: b4, d9, g3, g6, h2, h3 and h11.The product has been returned for evaluation and testing; however, the engineering evaluation has not been completed.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CERENOVUS ENTERPRISE
Common Device Name
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
henry boden
31 technology dr
irvine, CA 92618
9497882078
MDR Report Key24715279
Report Number3008114965-2026-00468
Device Sequence Number5763625
Product Code NJE
UDI-Device Identifier10878528009525
UDI-Public(01)10878528009525(17)270728(10)10056839
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
H60001
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 04/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberENC452200
Device Lot Number10056839
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/22/2026
Supplement Date Received by Manufacturer04/20/2026
04/23/2026
Initial Report FDA Received Date03/30/2026
Supplement Report FDA Received Date04/21/2026
04/27/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/11/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-